RSNA 2014 

Abstract Archives of the RSNA, 2014


SSE11-02

Different Hydration Regimens for Prevention of Contrast-induced Nephropathy in Patients with Renal Insufficiency Undergoing Coronary Angiography or Intervention

Scientific Papers

Presented on December 1, 2014
Presented as part of SSE11: ISP: Genitourinary (Intravenous Contrast Issues in Uroradiology)

Participants

Ya-Chen Zhang, Abstract Co-Author: Research Grant, General Electric Company
Yong Tang, Abstract Co-Author: Research Grant, General Electric Company
Jian Chen, Abstract Co-Author: Research Grant, General Electric Company
Qing Zhou, Abstract Co-Author: Research Grant, General Electric Company
Yu-Quan Xie, Abstract Co-Author: Research Grant, General Electric Company
Man-Tian Chen, Abstract Co-Author: Research Grant, General Electric Company
Shu Meng, Abstract Co-Author: Research Grant, General Electric Company
Cheng-Xing Shen, Abstract Co-Author: Research Grant, General Electric Company
Yi-Gang Li, Abstract Co-Author: Research Grant, General Electric Company
Xiaozheng Yang, Presenter: Research Grant, General Electric Company

PURPOSE

Though hydration is one of widely accepted methods to decrease the incidence of contrast-induced acute kidney injury (CI-AKI), the regimens and concentration for hydration was still debatable. The study was going to compare the effectiveness of 3 kinds of hydration regimens used routinely in clinical for prevention of CI-AKI in patients with renal insufficiency undergoing percutaneous coronary intervention or angiography (PCI).

METHOD AND MATERIALS

300 patients with serum creatinine (SCr) > 97 μmol/L undergoing PCI were randomized into 3 different groups equally. 0.45% (w/w) sodium chloride was given to group 1 at a rate of 1ml/kg/h 12h before and after procedure. Group 2 received 0.9% (w/w) sodium chloride with the same administration strategy. Group 3 was treated with 1.25% (w/w) sodium bicarbonate 1h before procedure (3ml/kg/h), 6h after procedure (1ml/kg/h). Iodixanol 320 mgI/ml (Visipaque, GE Healthcare) was given during all procedure with a volume of 95 - 190 ml. The primary endpoint was incidence of CI-AKI defined as a relative increase in Scr of ≧ 25% from baseline in 72 hours after administration of contrast. Secondary endpoints were the incidence of major adverse cardiac and cerebral events (including allcause death, myocardial infarction (MI), re-PCI, and stroke) in 6 months after procedure.

RESULTS

All subjects finished the study and were eligible for analysis. The average Scr peaked in 48 hour in all groups. Group 1 had a significantly highest peaked level of SCr (116.9 ± 20.5) than other two groups (P < 0.05), while there was no significant difference between group 2 and group 3 (110.6 ± 12.5 vs 113.4 ± 12.1). The incidence of CI-AKI in group 1, group 2 and group 3 were 12%, 4%, 3%, respectively (all P < 0.05). Patients developed CI-AKI after procedure had greater risk of MI than patients without CI-AKI (Log-rank test, P < 0.01).

CONCLUSION

When PCI needs to be done on patients with renal insufficiency, using 1.25% sodium bicarbonate solution for hydration can not only reduce the risk of developing CI-AKI, but also improve the longterm prognosis.

CLINICAL RELEVANCE/APPLICATION

This study provided vital clinical proofs on hydration application for PCI. Patients benefit most from hydration with 1.25% sodium bicarbonate. With a shorter time of pre-procedure, this regimen is also practicable in emergent PCI.

Cite This Abstract

Zhang, Y, Tang, Y, Chen, J, Zhou, Q, Xie, Y, Chen, M, Meng, S, Shen, C, Li, Y, Yang, X, Different Hydration Regimens for Prevention of Contrast-induced Nephropathy in Patients with Renal Insufficiency Undergoing Coronary Angiography or Intervention.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14010193.html